Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - AMERICAN BIO MEDICA CORP | abmc_10k.htm |
| EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - AMERICAN BIO MEDICA CORP | abmc_ex311.htm |
EXHIBIT 32.1/EXHIBIT 32.2
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of American Bio Medica
Corporation (the “Company”) on Form 10-K for the period
ending December 31, 2020 as filed with the Securities and Exchange
Commission on April 15, 2021 (the
“Report”), I, Melissa A. Waterhouse, Chief Executive
Officer and Principal Financial Officer of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of
the Sarbanes-Oxley Act of 2002, that:
(1) The
Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
/s/ Melissa A.
Waterhouse
Melissa A.
Waterhouse
Principal Financial
Officer
Principal
Accounting Officer
April
15, 2021